Pediatric Advances

NewYork-Presbyterian

Advances in Pediatric Oncology

Our pediatric oncology team provides advanced cancer care for children of all ages.

Fighting cancer takes a team, and our pediatric oncology team at NewYork-Presbyterian Morgan Stanley Children's Hospital and NewYork-Presbyterian Komansky Children's Hospital is made up of internationally recognized specialists who collaborate to provide individualized care for each patient. We provide access to groundbreaking pediatric clinical trials and are the only institution in New York designated by the National Cancer Institute to conduct Phase I pediatric clinical trials — the earliest phase of studies for patients.

image of bald child undergoing chemotherapy
Oncology

A Concerted Approach to Targeted Care for Pediatric Cancers

Graphic of Current Clinical Trials Portfolio for Columbia Developmental Therapeutics Program
Oncology

Developmental Therapeutics: Providing Hope for Children with Refractory Cancer

image of mother hugging daughter with cancer
Oncology

Addressing Reproductive Implications for Childhood Cancer Survivors

images of girl with hair wrap looking out the window with sad face
Oncology

Closing the Care Gap: Adolescents and Young Adults with Lymphoma

images of immunofluorescence staining of cells with and without drug treatment
Oncology

EBV-Associated Lymphomas: New Treatment Approach Could Benefit Children Here and Abroad

Chronic myeloid leukemia (CML) cells under microscope
Oncology

Pediatric CML: Confirming Growth Consequences Associated with Nilotinib Treatment

image of masked mom holding and hugging masked teenager cancer patient
Oncology

COVID-19: Pediatric Oncologists Address Challenging Issues

image of Dr. Adolfo Ferrando
Oncology

Compelling Research in Acute Lymphoblastic Leukemia

image of Dr. Kaicker, Dr. Schussler, and Dr. Bassetti
Hematology & Oncology

Uncovering The Immunological Basis of Cytopenias In Childhood

image of Dr. Lisa G. Roth
Oncology

Adolescent and Young Adult Lymphoma Program

image of Dr. Prakash Satwani
Oncology

CAR T-Cell Therapy: A Reason to Hope in Hematological Malignancy